开始
TradeWithTyler

CLRB Phase 1 Success

Cellectar Biosciences, Inc. (NASDAQ:CLRB)  
TradeWithTyler  
NASDAQ:CLRB   Cellectar Biosciences, Inc.
Trend Analysis Chart Patterns Technical Indicators CLRB Stocks
1
0
trendanalysis chartpattern indicator clrb stocks
Positive news today "CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma". This stock Shs Float is 5.15M, and Market Cap 14.76M.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。